DAVITA INC's ticker is DVA and the CUSIP is 23918K108. A total of 460 filers reported holding DAVITA INC in Q2 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cannell & Co. | 26,430 | $2,655,422 | 0.09% |
| AustralianSuper Pty Ltd | 134,760 | $13,539,337 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 40,694 | $4,089 | 0.08% |
| State of Wyoming | 2,725 | $273,781 | 0.08% |
| Deseret Mutual Benefit Administrators | 1,982 | $199,132 | 0.08% |
| Coastline Trust Co | 5,420 | $544,547 | 0.08% |
| Sowell Financial Services LLC | 12,220 | $1,228,000 | 0.07% |
| Bridgecreek Investment Management, LLC | 3,500 | $351,645 | 0.07% |
| FIRST CITIZENS BANK & TRUST CO | 35,787 | $3,595,519 | 0.07% |
| ARS Wealth Advisors Group, LLC | 4,100 | $411,927 | 0.06% |
| Woodline Partners LP | 54,800 | $5,505,756 | 0.06% |
| GTS SECURITIES LLC | 20,066 | $2,016,031 | 0.06% |
| GABELLI FUNDS LLC | 82,500 | $8,288,775 | 0.06% |
| Covestor Ltd | 753 | $76 | 0.06% |
| Kinneret Advisory, LLC | 4,905 | $492,805 | 0.06% |
| BNP PARIBAS FINANCIAL MARKETS | 464,187 | $46,636,868 | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 1,173,983 | $117,950,072 | 0.06% |
| Bridgewater Associates | 91,920 | $9,235,202 | 0.06% |
| Quantinno Capital Management LP | 9,955 | $1,000,000 | 0.06% |
| HRT FINANCIAL LP | 59,198 | $5,947 | 0.06% |
About DAVITA INC
DaVita Inc. is a leading provider of kidney care services in the United States. The company operates more than 2,700 dialysis clinics across the country, serving approximately 203,000 patients. DaVita's mission is to improve the quality of life for those living with kidney disease, and the company is committed to providing high-quality, compassionate care to its patients.
DaVita's success can be attributed to its focus on patient-centered care. The company's care teams work closely with patients to develop personalized treatment plans that meet their unique needs. DaVita also invests heavily in technology and innovation to improve patient outcomes and enhance the overall patient experience.
In addition to its core kidney care services, DaVita also operates a number of strategic business units, including DaVita Kidney Care, DaVita Medical Group, and DaVita International. These units allow the company to diversify its revenue streams and expand its reach into new markets.
Despite its success, DaVita faces a number of challenges in the highly competitive healthcare industry. The company must navigate complex regulatory environments, manage rising healthcare costs, and adapt to changing patient needs and preferences.
Overall, DaVita is a strong player in the kidney care market, with a proven track record of delivering high-quality care to its patients. As the healthcare industry continues to evolve, DaVita will need to remain agile and innovative to stay ahead of the curve.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DAVITA INC's shareholders in Q2 2023. To view DAVITA INC's shareholder history, click here.